OvaMed (Altrenogest) Solution for Horses, 1000-mL

OvaMed is a progestin used to suppress estrus cycles in mares to maximize breeding efficiency. OvaMed can help reduce moodiness and temperament changes due to estrus. May also be used to keep your mare out of heat.

**Proudly sourced directly from the manufacturer or their approved distributor. Guaranteed genuine and backed by the manufacturer.**

Specifications

Item Number : 178062
Generic Name :
Common Brand Name(s) :
For Use With :
Administration Form :
Product Form :
Health Condition :
Drug Type :

Ingredients

Ingredients
Altrenogest.

Instructions

Recommended Dosage
Detach syringe and administer solution orally at the rate of 1mL per 110 pounds body weight (0.044 mg/kg) once daily for 15 consecutive days.

Storage Instructions
Store at or below 77°F.

FAQ

**What if I’m accidentially exposed to the product?**

Altrenogest is readily absorbed from contact with the skin. In addition, this oil based product can penetrate porous gloves. Altrenogest should not penetrate intact rubber or impervious gloves; however, if there is leakage (i.e., pinhole, spillage, etc.), the contaminated area covered by such occlusive materials may have increased absorption. The following measures are recommended in case of accidental exposure.
* Skin Exposure: Wash immediately with soap and water.
* Eye Exposure: Immediately flush with plenty of water for 15 minutes. Get medical attention.
* If Swallowed: Do not induce vomiting. OvaMed contains an oil. Call a physician. Vomiting should be supervised by a physician because of possible pulmonary damage via aspiration of the oil base. If possible bring the container and labeling to the physician.

Who should not handle this product?

* Women who are or suspect they are pregnant.
* Anyone with thrombophlebitis or thromboembolic disorders or with a history of these events.
* Anyone with cerebral-vascular or coronary-artery disease.
* Women with known or suspected carcinoma of the breast.
* People with known or suspected estrogen-dependent neoplasia.
* Women with undiagnosed vaginal bleeding.
* People with benign or malignant tumors which developed during the use of oral contraceptives or other estrogen-containing products.
* Anyone with liver dysfunction or disease.